Open AccessShort-Term COVID-19 Pandemic-Related Endoscopy Delays Did Not Translate to Deleterious Outcomes for Patients With Inflammatory Bowel Disease: A Retrospective Cohort Study
Author(s) -
Jason Chambers,
Gurpreet Malhi,
Maria Mikail,
Reena Khanna,
Aze Wilson
Publication year - 2022
Publication title -
journal of the canadian association of gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 2515-2092
pISSN - 2515-2084
DOI - 10.1093/jcag/gwac009
Subject(s) - pandemic , medicine , covid-19 , retrospective cohort study , inflammatory bowel disease , endoscopy , disease , term (time) , cohort , cohort study , intensive care medicine , virology , infectious disease (medical specialty) , outbreak , physics , quantum mechanics
The management of inflammatory bowel disease (IBD) requires frequent endoscopic assessment. It is unknown if measures put in place to reduce the spread of the virus SARS-CoV-2, including the delay of non-urgent patient assessments, resulted in deleterious outcomes for patients with IBD. Therefore, we aimed to determine if delays in endoscopy during the COVID-19 pandemic were associated with an increased risk of adverse IBD outcomes (emergency room, ER presentation, hospitalization, surgery, or escalation of drug therapy).